Personal Cfo Solutions, LLC Acadia Pharmaceuticals Inc Transaction History

Personal Cfo Solutions, LLC

$482 Million
Q1 2025

A detailed history of Personal Cfo Solutions, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Personal Cfo Solutions, LLC holds 12,152 shares of ACAD stock, worth $276,336. This represents 0.04% of its overall portfolio holdings.

Number of Shares

12,152

Previous 12,230 0.64%

Holding current value

$276,336

Previous $224,000 10.27%

% of portfolio

0.04%

Previous 0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 30, 2025	SELL	$16.61 - $20.29 $1,295 - $1,582	-78 Reduced 0.64%	12,152 $201,000
Q4 2024 Feb 07, 2025	BUY	$14.29 - $18.76 $174,766 - $229,434	12,230 New	12,230 $224,000
Q2 2024 Aug 09, 2024	SELL	$14.62 - $18.42 $2,587 - $3,260	-177 Reduced 1.38%	12,614 $204,000
Q1 2024 May 13, 2024	SELL	$17.79 - $30.86 $658 - $1,141	-37 Reduced 0.29%	12,791 $236,000
Q4 2023 Feb 13, 2024	BUY	$20.78 - $31.77 $415 - $635	20 Added 0.16%	12,828 $401,000
Q3 2023 Nov 13, 2023	BUY	$20.84 - $33.47 $562 - $903	27 Added 0.21%	12,808 $266,000
Q2 2023 Aug 10, 2023	SELL	$17.8 - $25.65 $1,406 - $2,026	-79 Reduced 0.61%	12,781 $306,000
Q1 2023 May 09, 2023	BUY	$16.32 - $20.92 $228 - $292	14 Added 0.11%	12,860 $242,000
Q4 2022 Feb 14, 2023	SELL	$14.2 - $18.63 $49,700 - $65,205	-3,500 Reduced 21.41%	12,846 $204,000
Q2 2022 Aug 05, 2022	BUY	$13.01 - $27.22 $6,505 - $13,610	500 Added 3.16%	16,346 $230,000
Q1 2022 May 02, 2022	BUY	$20.94 - $27.5 $20,940 - $27,500	1,000 Added 6.74%	15,846 $384,000
Q4 2021 Feb 11, 2022	SELL	$16.79 - $27.09 $220,855 - $356,341	-13,154 Reduced 46.98%	14,846 $347,000
Q3 2021 Nov 18, 2021	BUY	$15.78 - $24.77 $44,184 - $69,356	2,800 Added 11.11%	28,000 $465,000
Q1 2021 Apr 21, 2021	BUY	$25.02 - $54.99 $85,068 - $186,966	3,400 Added 15.6%	25,200 $650,000
Q3 2020 Nov 02, 2020	BUY	$36.42 - $57.0 $36,420 - $57,000	1,000 Added 4.81%	21,800 $1,000
Q2 2020 Aug 03, 2020	BUY	$39.26 - $52.73 $121,706 - $163,463	3,100 Added 17.51%	20,800 $1.01 Million
Q1 2020 Apr 30, 2020	BUY	$31.65 - $46.87 $256,365 - $379,647	8,100 Added 84.38%	17,700 $748,000
Q4 2019 Feb 13, 2020	BUY	$36.21 - $51.4 $347,616 - $493,440	9,600 New	9,600 $411,000

Others Institutions Holding ACAD

# of Institutions

350

Shares Held

164M

Call Options Held

811K

Put Options Held

334K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.68B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Cfo Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Personal Cfo Solutions, LLC with notifications on news.

Account

Personal Cfo Solutions, LLC Acadia Pharmaceuticals Inc Transaction History